Alcon has inaugurated a new manufacturing plant in Singapore to produce ophthalmic pharmaceutical products. Construction on this 330,000-square-foot facility, located in the Tuas Biomedical Park, began in 2009, and represents an investment of around S$200 million (€114.85m-$159.27m). The location was strategically chosen to be closer and able to respond quickly ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.